Overview

68Ga-FAPI PET/CT in Liver Fibrosis Patients

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the potential value of 68Ga-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis and prognosis in liver fibrosis disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University